September 29, 2025

Addition of Xevinapant to Platinum-Based Chemoradiotherapy in Unresected Locally Advanced Squamous Cell Carcinoma of the Head and Neck

In a phase III trial (TrilynX) reported in the Journal of Clinical Oncology, Bourhis et al found that the addition of xevinapant (an inhibitor of apoptosis proteins inhibitor) to platinum-based chemor...

The ASCO Post

September 23, 2025

Innovative Roswell Park Radiation Therapy Protocol in Lung Cancer to Be Highlighted at ASTRO Annual Meeting

Experts from Roswell Park Comprehensive Cancer Center will share the findings of a novel approach using radiation therapy to treat lung cancer at the American Society for Radiation Oncology (ASTRO) Annual Meeting Sept. 27-Oct. 1, 2025, in San Francisco.

Roswell Park Comprehensive Cancer Center

September 22, 2025

Metastasis-Directed Radiotherapy for Oligometastatic Clear Cell Renal Cell Carcinoma

In a single-center phase II trial reported in The Lancet Oncology, Tang et al found that metastasis-directed radiotherapy without systemic therapy was associated with good outcomes in patients with ol...

The ASCO Post

September 24, 2025

Advancing Clinical Oncology: Research Highlights from Baptist Health South Florida

Across Baptist Health South Florida, physician-researchers are leading studies that not only generate novel insights but also accelerate the translation of innovation into clinical protocols.

Baptist Health South Florida

September 18, 2025

Leading Societies Update Clinical Guideline on Postmastectomy Radiation Therapy

ASCO, ASTRO, and SSO have issued an updated guideline on postmastectomy radiation therapy (PMRT) for physicians treating patients with breast cancer. The recommendations outline when PMRT is appropria...

The ASCO Post

March 12, 2025

As Technology Progresses, Aneurysm Treatments Become Safer and More Reasonable to Consider

Observing the 2.4 mm aneurysm in one female patient seemed reasonable in 2013. But when the evolution of endovascular techniques and technology provided an opportunity to cure her aneurysm in 2024, the 70-year-old patient sought treatment at Mount Sinai’s Cerebrovascular Center. By then, imaging had revealed the aneurysm to be nearly 7 mm in size.

Mount Sinai New York

September 30, 2024

Fox Chase Cancer Center Researchers Show Adaptive Radiation Therapy Delivers Treatment More Effectively in Study Presented at American Society for Radiation Oncology Meeting

Online adaptive radiation therapy (ART) delivered radiation more effectively than conventional radiation therapy in nearly half of patients, while also helping to decrease radiation dose to the esophagus in a majority of patients with thoracic spine tumors. That’s according to the results of a study presented today by Fox Chase Cancer Center researchers at the American Society for Radiation Oncology (ASTRO) Annual Meeting in Washington, D.C.

Fox Chase Cancer Center

February 01, 2022

Patient Safety and Comfort Drive Shift in Arterial Access

For neurointerventional radiology procedures, arterial access is critical. The femoral artery has long been the go-to access point. But, say doctors at Marcus Neuroscience Institute at Boca Raton Regional Hospital, a part of Baptist Health South Florida, radial access may be better for many patients.

Baptist Health South Florida

June 13, 2025

Weight Loss Drugs Show Promise for Heart Failure

ACC statement highlights semaglutide and tirzepatide as therapies associated with improved symptoms and functional capacity in patients with heart failure with preserved ejection fraction and obesity.

Conexiant